N@N

Robyn Karnauskas Downgraded (BIIB) to Hold on, Oct 23rd, 2017

Robyn Karnauskas of Citigroup, Downgraded "Biogen Inc." (BIIB) to Hold on, Oct 23rd, 2017.

Robyn has made no other calls on BIIB in the last 4 months.

There are 10 other peers that have a rating on BIIB. Out of the 10 peers that are also analyzing BIIB, 4 agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Brian Abrahams of "RBC Capital" Initiated at Hold and Held Target at $319 on, Friday, September 15th, 2017
• Jeffrey Silber of "BMO Capital" Maintained at Hold with Increased Target to $377 on, Wednesday, September 13th, 2017
• Carter Gould of "UBS" Maintained at Hold with Increased Target to $285 on, Wednesday, July 26th, 2017
• Eun Yang of "Jefferies" Initiated at Hold and Held Target at $310 on, Tuesday, July 11th, 2017

These are the ratings of the 6 analyists that currently disagree with Robyn

---

• Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $365 on, Wednesday, October 18th, 2017
• Salim Syed of "Mizuho" Upgraded from Hold to Strong Buy on, Tuesday, October 17th, 2017
• Thomas Shrader of "Stifel" Upgraded from Hold to Strong Buy on, Tuesday, October 17th, 2017
• Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy on, Thursday, October 5th, 2017
• Terence Flynn of "Goldman Sachs" Upgraded at Strong Buy on, Wednesday, August 16th, 2017
• Andrew Peters of "Deutsche Bank" Initiated at Strong Buy and Held Target at $315 on, Friday, June 23rd, 2017

Contributing Sources

---